Shift work, insufficient sleep and other disrupters of circadian activity increase the risk of metabolic syndrome, characterized by obesity, insulin resistance, dyslipidemia, hypertension, and cardiovascular morbidity. The next cycle of Project #3 will investigate interactions of the brain and peripheral organs in a feeding entrainment model in mice that mimic metabolic disorders resulting from circadian disruption in humans. Mice restricted to 5 hours feeding during the light cycle (L-Fed) develop hypothalamic leptin insensitivity and elevation of resistin levels in 1 week, followed by hepatic steatosis, insulin resistance and obesity. Hepatic CREB coactivator (Crtc2) is increased and Akt activation is blunted in L-Fed mice. We hypothesize that the signaling of leptin and resistin in the brain and liver are crucial for the pathogenesis of steatosis, insulin resistance and obesity in L-Fed mice.
Aim 1 will determine how enhanced leptin sensitivity in the hypothalamus resulting from Tyr985 knock-in mutation in the leptin receptor or Socs3 deletion in AGRP and POMC neurons affects energy homeostasis, and glucose and lipid metabolism during feeding entrainment.
Aim 2 will determine how leptin interacts with Crtc2 and Akt2 in the liver to regulate glucose and lipid metabolism during feeding entrainment.
Aim 3 will determine whether resistin knockout mice are protected against insulin resistance during feeding entrainment, and whether Socs3 mediates resistin's ability to induce insulin resistance. The proposed studies will address critical mechanisms underiying the development of obesity and metabolic dysregulation in mice restricted to feeding during the day. The project will benefit from collaborations with other P01 investigators, and has the potential to provide novel pathophysiological mechanisms and therapies for obesity, diabetes and dyslipidemia associated with disruption of circadian rhythms.
Shift work and other activities that disrupt circadian rhythms increase the risk of obesity, diabetes and heart disease. This project will evaluate the metabolic effects of fat-derived hormones in a mouse model that resembles circadian disruption in humans. We will determine how disruption of the timing of feeding affects the actions of leptin and resistin, and how these fat hormones act in the brain and peripheral organs to cause fatty liver, insulin resistance and obesity.
|Juliana, Christine A; Yang, Juxiang; Cannon, Corey E et al. (2018) A PDX1-ATF transcriptional complex governs ? cell survival during stress. Mol Metab 17:39-48|
|Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705|
|Kim, Yong Hoon; Marhon, Sajid A; Zhang, Yuxiang et al. (2018) Rev-erb? dynamically modulates chromatin looping to control circadian gene transcription. Science 359:1274-1277|
|Plikus, Maksim V; Guerrero-Juarez, Christian F; Ito, Mayumi et al. (2017) Regeneration of fat cells from myofibroblasts during wound healing. Science 355:748-752|
|Juliana, Christine A; Yang, Juxiang; Rozo, Andrea V et al. (2017) ATF5 regulates ?-cell survival during stress. Proc Natl Acad Sci U S A 114:1341-1346|
|Ediger, Benjamin N; Lim, Hee-Woong; Juliana, Christine et al. (2017) LIM domain-binding 1 maintains the terminally differentiated state of pancreatic ? cells. J Clin Invest 127:215-229|
|Jang, Jessica C; Li, Jiang; Gambini, Luca et al. (2017) Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction. Proc Natl Acad Sci U S A 114:E10399-E10408|
|Carr, Rotonya M; Dhir, Ravindra; Mahadev, Kalyankar et al. (2017) Perilipin Staining Distinguishes Between Steatosis and Nonalcoholic Steatohepatitis in Adults and Children. Clin Gastroenterol Hepatol 15:145-147|
|Park, Hyeong Kyu; Kwak, Mi Kyung; Kim, Hye Jeong et al. (2017) Linking resistin, inflammation, and cardiometabolic diseases. Korean J Intern Med 32:239-247|
|Ackermann, Amanda M; Zhang, Jia; Heller, Aryel et al. (2017) High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting. Mol Metab 6:236-244|
Showing the most recent 10 out of 220 publications